MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
2.630
+0.080 (3.14%)
Apr 17, 2025, 4:00 PM EDT - Market closed
MaxCyte Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for MaxCyte stock have an average target of 10, with a low estimate of 9.00 and a high estimate of 11. The average target predicts an increase of 280.23% from the current stock price of 2.63.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 12, 2025.
Analyst Ratings
The average analyst rating for MaxCyte stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $11 → $9 | Strong Buy | Maintains | $11 → $9 | +242.21% | Mar 12, 2025 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +318.25% | Apr 23, 2024 |
| Stephens & Co. | Stephens & Co. | Buy Reiterates $11 | Buy | Reiterates | $11 | +318.25% | Mar 13, 2024 |
| BTIG | BTIG | Strong Buy Maintains $10 → $8 | Strong Buy | Maintains | $10 → $8 | +204.18% | Mar 13, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Initiates $7 | Strong Buy | Initiates | $7 | +166.16% | Nov 29, 2023 |
Financial Forecast
Revenue This Year
42.12M
from 38.63M
Increased by 9.05%
Revenue Next Year
50.54M
from 42.12M
Increased by 19.98%
EPS This Year
-0.36
from -0.39
EPS Next Year
-0.31
from -0.36
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 44.2M | 54.4M | 93.3M | ||
| Avg | 42.1M | 50.5M | 90.6M | ||
| Low | 39.5M | 46.1M | 87.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 14.4% | 29.1% | 84.6% | ||
| Avg | 9.1% | 20.0% | 79.4% | ||
| Low | 2.2% | 9.3% | 72.3% |
EPS Forecast
| EPS | 2025 | 2026 |
|---|---|---|
| High | -0.35 | -0.30 |
| Avg | -0.36 | -0.31 |
| Low | -0.40 | -0.34 |
EPS Growth
| EPS Growth | 2025 | 2026 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.